1851 – 1860 of 2181
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma
(
- Contribution to journal › Article
-
Mark
Review: the function of blood group-specific RBC membrane components.
(
- Contribution to journal › Article
-
Mark
Biosynthesis and sorting of myeloperoxidase in hematopoietic cells.
(
- Contribution to journal › Article
-
Mark
Inhibition of xenogeneic GVHD by PEN110 treatment of donor human PBMNCs
(
- Contribution to journal › Article
-
Mark
Leucodepletion and immune response mechanisms
(
- Contribution to journal › Article
- 2003
-
Mark
Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB
(
- Contribution to journal › Article
-
Mark
CHOP is superior to CNOP in elderly patients with aggressive lymphoma while outcome is unaffected by filgrastim treatment: results of a Nordic Lymphoma Group randomized trial
(
- Contribution to journal › Article
-
Mark
The pharmacokinetics of clotting factor therapy.
(
- Contribution to journal › Article
-
Mark
Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized.
(
- Contribution to journal › Article
-
Mark
Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study
(
- Contribution to journal › Article